| INTRODUCTION
Urine processing to improve direct identification of uropathogens using matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) could improve the quantity of extracted and purified bacterial biomass, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] facilitated primarily by the high bacterial counts in infected urine. 2, 12 Overall, currently published methods for direct identification from urine have used differential centrifugation, 8, 10 which combines MALDI-TOF MS with complex extraction protocols using pre-or post-treatment. Such protocols include the use of lysis solutions, such as special detergents (sodium dodecyl sulfate [SDS] or tween 80) 2, 3, 7 or organic solvents (formic acid or acetonitrile); 4, 6, 10 filter systems, such as vacuum-filter, dual-filter, or diafiltration units; 1, 5, 11 or short-time bacterial cultivation on solid media. 9 To date, the accuracy of these methods compared with conventional culture techniques has ranged from 58% to 92%. Moreover, these complex protocols require large volumes (≥10-15 mL) 1, 11 and special equipment and are technically complex, labor intensive, and expensive for routine use in clinical practice.
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Other drawbacks of these techniques are that insufficient bacteria are usually obtained from urine samples and that they require different thresholds for identifying microorganisms depending on the species. 6, 7 In addition, urine culture is the gold standard for microbiological confirmation of UTIs, but up to 80% of urine culture samples have been reported to be negative. 13 Therefore, an algorithm for preselecting urine samples depending on the bacterial load could be of use before MALDI-TOF MS. Rapid urine screening methods such as
Gram staining as well as automated urine screening devices like the UF-1000i (Sysmex Corporation, Kobe, Japan) allow the detection of the presence or absence of microorganisms and are able to identify possibly positive urine samples for bacterial cultures. [6] [7] [8] [9] 14 However, performing Gram staining appropriately shows inter-observer variation, and the application of UF-1000i for screening has resulted in contradictory results if screening is performed with the urine flow cytometry method alone. 14, 15 In our study, we evaluated the performance of Bruker MS (Bruker MALDI-TOF; Bruker Daltonik, Bremen, Germany) with urine prepared with NaOH-HCl neutralization for direct testing of urine samples. We also aimed to establish a protocol, combining this approach with conventional screening tests for proper workflow in clinical microbiology laboratories. 
| MATERIALS AND METHODS

| Clinical samples
| Statistical analysis
Mean biotype confidence scores for the proprietary algorithm are reported. Data analyses were performed using SPSS v 22.0 (SPSS Inc., Chicago, IL, USA). We used chi-squared analyses and Fisher exact tests to compare proportions, as appropriate with P-values≤.05 considered as statistically significant. ony morphologies on agar, all had UF-1000i counts ≥10 6 bacteria/mL, and two of the samples had a single morphotype on Gram staining. In 27 samples, we identified more than two colony morphologies that were considered contaminants, and 14 (51.9%) of these had UF-1000i counts ≥10 6 bacteria/mL, and 15 (55.6%) had a single morphotype on
| RESULTS
| Gram stain and UF-1000i urine flow cytometry detection
Gram staining (Table 1) . 
| MALDI-TOF analysis using the 0.01 mol/L NaOH-HCl neutralization method
Of a total of 125 urine samples tested with urine culture and Bruker MS, 94 samples had a single colony morphology on agar. Eighty-two samples had colony counts ≥10 5 CFU/mL and most uropathogens 
UF1000i, bacteria/mL
No. Among 28 samples with three colony morphologies or no growth on agar, Bruker MS was unable to correctly identify any of the bacteria.
UF1000i
| Low detection limit in Bruker MS
Our 0.01 mol/L NaOH-HCl neutralization method for protein extraction showed the detection limit with a confidence score of the genus identification level of 10 7 CFU/mL for E. coli in the sterile saline and urine specimens; it also yielded a limit of 10 7 CFU/mL for E. faecium using both diluents in pellets. Using the 0.1% SDS-NaHCO 3 extraction method described by Kim et al. 3 , the detection limit was 10 7 CFU/mL for E.coli only in the sterile saline and for E. faecium using only pellets in the sterile saline. Using the intact cell method, neither E.coli nor E. faecium was detected at colony counts of 10 7 CFU/mL.
| DISCUSSION
We proposed the MALDI-TOF MS method in which urine was prepared for bacterial protein extraction by NaOH-HCl neutralization.
To more accurately predict bacteriuria, we prospectively studied MALDI-TOF analysis performed on the same day as urine culture.
Several previous studies on the direct identification of uropathogens
by MALDI-TOF MS have been retrospectively performed using primarily culture-positive specimens. 8, 11, 17 These study designs could be subjected to bias as the use of already defined clinical specimens could result in false-positive results, such as identifying clinically insignificant organisms, contamination with mixed flora, or a relatively high prevalence of positive cultures.
In addition, all samples for which Gram staining, UF-1000i, and urine culture were performed were requested by a physician. Gram staining is particularly helpful for inpatient care because it can diagnose the cause of sepsis before blood cultures are positive. However, its reported accuracy when used to diagnose UTI is inconsistent, with different microorganism counts being reported in different samples. 7, 18, 19 It should also only be performed on request, because there is little T A B L E 2 Bacteria present among the 124 urine samples positive by Gram staining, UF1000i flow cytometry, and urine cultures
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No. we designed a study that preselected samples based on positivity by
UF1000i
Gram staining and UF-1000i screening.
By preselecting samples based on positivity by Gram staining and UF-1000i screening, the positive culture rate was very high (99.2%).
Previous studies based on UF-1000i screening or Gram staining alone have reported 91.6% and 93.6% culture positivity, respectively. 3, 10 When assessing the likelihood of uropathogens being causative for clinically relevant bacteriuria, UF-1000i counts ≥10 6 bacteria/mL and single morphotype Gram staining might represent an appropriate cutoff point for preselecting urine samples before direct MALDI-TOF MS (Table 1) . Considering significant uropathogens, 91.4% (85 of 93) had UF-1000i counts ≥10 6 bacteria/mL; however, counts at this level were only observed in 51.6% (16 of 31) of the nonsignificant uropathogens.
We observed that E. coli and Enterococcus spp. had UF-1000i bacterial counts of ≥10 7 bacteria/mL (88.2%, 60 of 68) and 10 6 -10 7 bacteria/mL (57.1%, 4 of 7) respectively. This may be due to the higher bacterial titers associated with GNB compared with GPC in some circumstances.
In this study, NaOH and HCl were used as pretreatment lysing solutions for bacterial protein extraction instead of special detergents or organic solvents. NaOH and HCl are the widely available reagents in clinical laboratories. Different methods have been used by researchers to dissociate target microorganisms from contaminating molecular entities, either by exposure to chemicals or by altering the environmental conditions. In this study, the efficacy of alkali treatment of the bacterial pellets was evaluated as a potential step for extracting host proteins that are tightly bound to the microbes before Bruker MS.
Kwon et al. 21 were proposed that samples with colony counts ≥10 5 CFU/mL in agar plate should be reported because they showed significant correlation with 73.9 times with UTIs. With the cutoff for UTI being defined as a monobacterial culture with counts ≥10 5 CFU/ mL on agar, 21 Bruker MS correctly identified 86.6% (71 of 82) of samples, with identification scores above the predefined threshold of 1.7
for reliability (mean scores as 2.105). Consistent with previous studies, 1, 3, 6, 8, 10 the identification rate was much higher for GNB than for GPC (85.1% and 62.5% respectively). Indeed, GPC and GNB isolates both showed higher mean identification scores of 2.127 and 2.013 Correctly identified uropathogens n=71 (86.6%)
respectively. In the method described by March Rosello et al., preincubation in brain-heart infusion broth was required to get an adequate bacteria counts for tests when UF-1000i counts <10 7 bacterial/mL were obtained. By contrast, UF-1000i bacterial counts ≥10 7 bacterial/ mL were sufficient to allow direct uropathogens identification with a sensitivity of 87.5%. 9 Using the NaOH-HCl preparation method in this study, we showed that 89.1% (69/77) of samples were correctly identified by Bruker MS when UF-1000i bacterial counts were ≥10 6 bacteria/mL (with scores >2 for GPC and GNB as well). Compared with pellet from GNB, the GPC pellet tended to be less well formed partly due to differences in the cell walls and being more resistant to cell lysis between the two organisms. To compare urine preparation by NaOH-HCl neutralization with other methods of bacterial protein extraction, we evaluated the detection limits of our method when E. coli and E. faecium were added to sterile de-ionized water and sterile urine specimens. Our method yielded a detection limit of 10 7 CFU/mL for both E. coli and E. faecium.
For the latter organism, only specimens with 3 mL urine samples, including the pellet, could reliably detect microorganisms at 10 7 CFU/ mL. It is possible that the 7%-8% of samples for which identification failure occurs in culture-independent direct MALDI-TOF MS is associated with the removal of interleukocytic microorganisms in the pellets after initial processing. 2 Therefore, after the first centrifugation step, we selected 3 mL samples of urine that included pellets instead of supernatant with the GPC isolates. It was hoped that this would improve the collection of S. aureus bacteria. The intact cell protocol has been reported to require at least 8×10 4 CFU/mL for E. coli and 1.5×10 5 CFU/mL for E. faecalis for inoculation when using sterile deionized water and sterile urine specimens with sequential dilution.
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When the intact cell protocol was performed, using 5 mL of urine 10, 17 or sterile DW containing <10 7 CFU/mL of bacteria, the resultant pellet was miniscule or nonvisible and we failed to recover any material for transfer onto the MALDI target plate. This finding is consistent with a previous report by DeMarco et al. 1 , indicating that the detection limit for the intact cell method was at colony counts of 10 5 CFU/mL with a mean confidence score of <1.7 (1.5±1.3).
There are important benefits to our method. Of note, the turnaround time of the procedure was less than 1 hour, all incubation steps were performed in room temperature, and samples with single morphotype by Gram stain or UF-1000i counts of 10 6-7 bacterial/mL did not require preincubation in brain-heart infusion broth. our method was simpler than the methods reported in previous studies, which required either incubation in a water bath 3 or short-time subcultures. 9 Moreover, the need for urine volumes of only 5 mL could be clinically relevant given that conventional urinalysis requires at least 10 mL of urine. Our method could allow direct urine preparation and diagnosis without the need for further urine sampling after
Gram staining, UF-1000i analysis, conventional cultures, and Bruker MS analysis. However, in the period with prospective analysis of urine samples, positive samples with Gram staining and UF 1000i analysis were less than 10% of all specimens. Therefore, we encountered a few positive urine results by Gram stain and UF-1000i. In addition, Bruker MS only correctly identified in a limited percentage (60%) for GPCpositive specimens, implying that a better pretreatment step is needed to identify GPC directly from urine specimens.
| CONCLUSION
Bruker MS with protein extraction by 0.01 mol/L NaOH-HCl neutralization allows for rapid, simple, cost-effective, and accurate bacterial identification directly from infected urine samples, especially when major uropathogens such as E. coli and E. faecalis are involved. Using
Bruker MS after the identification of a single morphotype on Gram staining and when there is a UF-1000i count ≥10 6 bacteria/mL may improve the efficiency of bacterial identification in routine practice.
